RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice

Cardiovascular Research

Volumn 82, Issue 2, 2009, Pages 371-381

  Sun, Li ^a,b   Ishida, Tatsuro ^b   Yasuda, Tomoyuki ^b   Kojima, Yoko ^b   Honjo, Tomoyuki ^b   Yamamoto, Yasuhiko ^c   Yamamoto, Hiroshi ^c   Ishibashi, Shun ^d   Hirata, Ken Ichi ^b   Hayashi, Yoshitake ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adhesion molecule; Atherosclerosis; Oxidative stress; Oxidized LDL; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CONTROLLED STUDY; FEMALE; FLUORESCENCE; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; KNOCKOUT MOUSE; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; AORTA; ATHEROSCLEROSIS; BLOOD GLUCOSE; CELLS, CULTURED; DIETARY FATS; DISEASE MODELS, ANIMAL; HYPERLIPIDEMIAS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; VASCULAR CELL ADHESION MOLECULE-1;

EID: 67449147073     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp036     Document Type: Article

References (28)

1. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108: 949-955.
2. Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FABEB J 1992; 6: 2905-2914.
3. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003; 93: 1159-1169.
4. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267: 14998-15004.
5. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 1992; 267: 14987-14997.
6. Brett J, Schmidt AM, Yan S, Zou YS, Weidman E, Pinsky D et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993; 143: 1699-1712.
7. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S et al. N(epsilon)-( carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 1999; 274: 31740-31749.
8. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Yet al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97: 889-901.
9. Cipollone F, lezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 2003; 108: 1070-1077.
10. Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999; 274: 19919-19924.
11. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001; 50: 2792-2808.
12. Huang SM, Wu CH, Yen GC. Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs. Mol Nutr Food Res 2006; 50: 1129-1139.
13. Shanmugam N, Kim YS, Lanting L, Natarajan R. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J Biol Chem 2003; 278: 34834-34844.
14. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 1998; 4: 1025-1031.
15. Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL et al. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch Biochem Biophys 2003; 419: 80-88.
16. Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 2002; 106: 2827-2835.
17. Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vase Biol 2005; 25: 1032-1037.
18. Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H et al. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 2006; 55: 2510-2522.
19. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993; 92: 883-893.
20. Ishida T, Choi SY, Kundu RK, Spin J, Yamashita T, Hirata K et al. Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 2004; 279: 45085-45092.
21. Münzel T, Afanas'ev IB, Kleschyov AL, Harrison DG. Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol 2002; 22: 1761-1768.
22. Harja E, Bu DX, Hudson BI, Chang JS, Shen X, Hallam K et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest 2008; 118: 183-194.
23. Reardon CA, Miller ER, Blachowicz L, Lukens J, Binder CJ, Witztum JL et al. Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. J Lipid Res 2004; 45: 1347-1354.
24. Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K et al. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Atherosclerosis 2000; 150: 343-355.
25. Binder CJ, Chang MK, Shaw PX, Miller Yl, Hartvigsen K, Dewan A et al. Innate and acquired immunity in atherogenesis. Not Med 2002; 8: 1218-1226.
26. Ge J, Jia Q, Liang C, Luo Y, Huang D, Sun A et al. Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler Thromb Vasc Biol 2005; 25: 2157-2163.
27. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21 (ras)dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997; 272: 17810-17814.
28. Zill H, Günther R, Erbersdobler HF, Fölsch UR, Faist V. RAGE expression and AGE-induced MAP kinase activation in Caco-2 cells. Biochem Biophys Res Commun 2001; 288: 1108-1111.